Education
About Us
Working with TipRanks
Follow Us
Chitogenx Inc. (CHNXF)
:CHNXF
CHNXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume39.22K
Average Volume (3M)3.00
Market Cap
$303.29K
Enterprise Value$4.60M
Total Cash (Recent Filing)$48.00K
Total Debt (Recent Filing)C$4.23M
Price to Earnings (P/E)―
Beta-1.41
Next Earnings
Jun 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding83,129,520
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-0.06
Price to Sales (P/S)0.00
P/FCF Ratio-2.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ChitogenX News
PremiumCompany Announcements
ChitogenX Shows Financial Improvement in Q3 2025PremiumCompany Announcements
ChitogenX Reports Financial Growth in Q2 2025
PremiumCompany Announcements
ChitogenX Shareholders Confirm Directors and Auditor
PremiumCompany Announcements
ChitogenX Advances Towards Commercial Readiness
PremiumCompany Announcements
ChitogenX Advances Regenerative Medicine and Finances
PremiumCompany Announcements
ChitogenX Inc. CEO Steps Down, Interim NamedOptions Prices
Currently, No data available
---
Ownership Overview
CHNXF FAQ
What was Chitogenx Inc.’s price range in the past 12 months?
Chitogenx Inc. lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is Chitogenx Inc.’s market cap?
Chitogenx Inc.’s market cap is $303.29K.
When is Chitogenx Inc.’s upcoming earnings report date?
Chitogenx Inc.’s upcoming earnings report date is Jun 02, 2025 which is 47 days ago.
How were Chitogenx Inc.’s earnings last quarter?
Currently, no data Available
Is Chitogenx Inc. overvalued?
According to Wall Street analysts Chitogenx Inc.’s price is currently Overvalued.
Does Chitogenx Inc. pay dividends?
Chitogenx Inc. does not currently pay dividends.
What is Chitogenx Inc.’s EPS estimate?
Chitogenx Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chitogenx Inc. have?
Chitogenx Inc. has 83,129,520 shares outstanding.
What happened to Chitogenx Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chitogenx Inc.?
Currently, no hedge funds are holding shares in CHNXF
Company Description
Chitogenx Inc.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
NanoSphere Health Sciences Inc
―
Biocure Technology Inc
―
Albert Labs International
―
Naturally Splendid
―
WPD Pharmaceuticals
―